Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuno Taveira

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|August 14, 2016
On the contribution of Angola to the initial spread of HIV-1Andrea-Clemencia Pineda-Peña, Jorge Varanda, João Dinis Sousa, et al.
Retrovirology|December 22, 2016
A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision supportMatthias Döring, Pedro Borrego, Joachim Büch, et al.
Journal of Clinical Medicine|February 25, 2023
Dental Implant Surface Decontamination and Surface Change of an Electrolytic Method versus Mechanical Approaches: A Pilot In Vitro StudyMariana Anselmo Assunção, João Botelho, Vanessa Machado, et al.
Viruses|January 8, 2025
Genetic Diversity and Antiretroviral Resistance in HIV-1-Infected Patients Newly Diagnosed in Cabo VerdeSilvânia Da Veiga Leal, Victor Pimentel, Paloma Gonçalves, et al.
Frontiers in Chemistry|October 24, 2022
Unveiling a family of spiro-β-lactams with anti-HIV and antiplasmodial activity <i>via</i> phosphine-catalyzed [3+2] annulation of 6-alkylidene-penicillanates and allenoatesAmérico J S Alves, Nuno G Alves, Inês Bártolo, et al.
Scientific Reports|April 27, 2021
Antibody response against selected epitopes in the HIV-1 envelope gp41 ectodomain contributes to reduce viral burden in HIV-1 infected patientsRute Marcelino, Filipa Gramacho, Francisco Martin, et al.
Plos One|December 31, 2013
Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in MozambiqueClaudia Palladino, Verónica Briz, José María Bellón, et al.
Plos One|July 18, 2017
Early infant diagnosis of HIV-1 infection in Luanda, Angola, using a new DNA PCR assay and dried blood spotsFrancisco Martin, Claudia Palladino, Rita Mateus, et al.
Nanoscale|August 15, 2015
Development of water-soluble polyanionic carbosilane dendrimers as novel and highly potent topical anti-HIV-2 microbicidesVerónica Briz, Daniel Sepúlveda-Crespo, Ana Rita Diniz, et al.
Antiviral Therapy|February 2, 2012
Baseline susceptibility of primary HIV-2 to entry inhibitorsPedro Borrego, Rita Calado, José M Marcelino, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|August 14, 2016
On the contribution of Angola to the initial spread of HIV-1Andrea-Clemencia Pineda-Peña, Jorge Varanda, João Dinis Sousa, et al.
Retrovirology|December 22, 2016
A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision supportMatthias Döring, Pedro Borrego, Joachim Büch, et al.
Journal of Clinical Medicine|February 25, 2023
Dental Implant Surface Decontamination and Surface Change of an Electrolytic Method versus Mechanical Approaches: A Pilot In Vitro StudyMariana Anselmo Assunção, João Botelho, Vanessa Machado, et al.
Viruses|January 8, 2025
Genetic Diversity and Antiretroviral Resistance in HIV-1-Infected Patients Newly Diagnosed in Cabo VerdeSilvânia Da Veiga Leal, Victor Pimentel, Paloma Gonçalves, et al.
Frontiers in Chemistry|October 24, 2022
Unveiling a family of spiro-β-lactams with anti-HIV and antiplasmodial activity <i>via</i> phosphine-catalyzed [3+2] annulation of 6-alkylidene-penicillanates and allenoatesAmérico J S Alves, Nuno G Alves, Inês Bártolo, et al.
Scientific Reports|April 27, 2021
Antibody response against selected epitopes in the HIV-1 envelope gp41 ectodomain contributes to reduce viral burden in HIV-1 infected patientsRute Marcelino, Filipa Gramacho, Francisco Martin, et al.
Plos One|December 31, 2013
Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in MozambiqueClaudia Palladino, Verónica Briz, José María Bellón, et al.
Plos One|July 18, 2017
Early infant diagnosis of HIV-1 infection in Luanda, Angola, using a new DNA PCR assay and dried blood spotsFrancisco Martin, Claudia Palladino, Rita Mateus, et al.
Nanoscale|August 15, 2015
Development of water-soluble polyanionic carbosilane dendrimers as novel and highly potent topical anti-HIV-2 microbicidesVerónica Briz, Daniel Sepúlveda-Crespo, Ana Rita Diniz, et al.
Antiviral Therapy|February 2, 2012
Baseline susceptibility of primary HIV-2 to entry inhibitorsPedro Borrego, Rita Calado, José M Marcelino, et al.
Pageof 9